Divis Laboratories is currently trading at Rs. 1370.05, up by 56.90 points or 4.33 % from its previous closing of Rs. 1313.15 on the BSE.
The scrip opened at Rs. 1365.00 and has touched a high and low of Rs. 1388.00 and Rs. 1350.00 respectively. So far 38004 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1388.00 on 04-Feb-2014 and a 52 week low of Rs. 905.00 on 05-Aug-2013.
Last one week high and low of the scrip stood at Rs. 1344.65 and Rs. 1239.00 respectively. The current market cap of the company is Rs. 18197.87 crore.
The promoters holding in the company stood at 52.12% while Institutions and Non-Institutions held 29.42% and 18.46% respectively.
Divis Laboratories has reported 51.84% rise in its net profit at Rs 219.02 crore for third quarter ended December 31, 2013 as compared to Rs 144.24 crore for the same quarter in the previous year. Total income of the company increased by 25.24% at Rs 697.18 crore for quarter under review as compared to Rs 556.68 crore for the quarter ended December 31, 2012.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1837.30 |
Dr. Reddys Lab | 1370.60 |
Cipla | 1495.05 |
Lupin | 2252.40 |
Zydus Lifesciences | 981.55 |
View more.. |